Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) FCF Margin (2021)

Historic FCF Margin for Cullinan Therapeutics (CGEM) over the last 1 years, with Q1 2021 value amounting to 8.0%.

  • Cullinan Therapeutics' FCF Margin changed N/A to 8.0% in Q1 2021 from the same period last year, while for Dec 2021 it was 229.28%, marking a year-over-year change of. This contributed to the annual value of 229.28% for FY2021, which is N/A changed from last year.
  • Latest data reveals that Cullinan Therapeutics reported FCF Margin of 8.0% as of Q1 2021.
  • In the past 5 years, Cullinan Therapeutics' FCF Margin ranged from a high of 8.0% in Q1 2021 and a low of 8.0% during Q1 2021